loading...

COA Instruments Distributed by Mapi Research Trust

default distrib

4DSQ / Four-Dimensional Symptom Questionnaire Four-Dimensional Symptom Questionnaire

Terluin B et al.

To distinguish stress-related syndromes (denoted as stress, burnout, nervous breakdown) and psychiatric disorders (i.e. depression and anxiety disorders)

Therapeutic indications : Generic for Psychiatry/Psychology

default distrib

A-LPQ / A-PPMRT / Angle Labor Pain Questionnaire / Angle Pictorial Pain Mapping & Pain Ranking Tool Angle Labor Pain Questionnaire / Angle Pictorial Pain Mapping & Pain Ranking Tool

Angle P, Kiss A, Landy CK et al.

A-LPQ: To measure women's multidimensional experiences of pain during labor and delivery A-PPMRT: To assist users with pain pattern identification and assessment during labor as well as to facilitate interpretation of A-LPQ findings

Therapeutic indications : Labor Pain, Pregnancy

default distrib

AAIQOL / Activity and Affect Indicators of QOL Activity and Affect Indicators of QOL

Albert SM et al.

To assess quality of life in dementia

Therapeutic indications : Alzheimer Disease, Affect, Dementia

default distrib

ABC-DS / ABC Dementia Scale ABC Dementia Scale

ABC Dementia Scale Study Group et al.

To assess Alzheimer’s Disease (AD) severity

Therapeutic indications : Alzheimer Disease

default distrib

aBCCdex / Advanced Basal Cell Carcinoma Index Advanced Basal Cell Carcinoma Index

Mathias SD, Chren MM, Crosby RD, Colwell HH, Yim YM, Reyes C, Chen DM, Fosko SW et al.

To evaluate the measurement properties of PRO questionnaires for use in patients with Advanced basal cell carcinoma (aBCC) and basal cell carcinoma naevus syndrome (BCCNS).

Therapeutic indications : Carcinoma, Basal Cell

default distrib

ABOUT™—Dependence / ABOUT™—Dependence ABOUT™—Dependence

Philip Morris Products S.A. et al.

To assess the perceived dependence associated with the use of a wide range of tobacco and nicotine-containing products

Therapeutic indications : Smoking, Smoking Cessation

default distrib

ABOUT™—Perceived Risk / ABOUT™—Perceived Risk (formally Perceived Risk Instrument - PRI) ABOUT™—Perceived Risk (formally Perceived Risk Instrument - PRI)

Philip Morris Products S.A. et al.

To assess the perceived risks associated with the use of tobacco and nicotine-containing products, including Conventional Cigarettes (CCs), Nicotine Replacement Therapy products (NRTs), and Reduced Risk Products (RRPs). The ABOUT™—Perceived Risk can also be used to assess the perceived risks associated with the past use of CC (e.g., ‘Cessation’).

Therapeutic indications : Smoking, Smoking Cessation

default distrib

ACCEPT / Chronic Treatment Acceptance Questionnaire Chronic Treatment Acceptance Questionnaire

Mapi et al.

The ACCEPT© questionnaire is a generic medication acceptance measure assessing how patients weigh advantages and disadvantages of long-term medications. ACCEPT© may be a predictor of patients' future adherence to and/or persistence with their treatment.

Therapeutic indications : All

default distrib

ACD / Asthma Control Diary Asthma Control Diary

Juniper E et al.

To measure the adequacy of clinical asthma control

Therapeutic indications : Asthma

default distrib

Acne-QoL / Acne Quality of Life Questionnaire Acne Quality of Life Questionnaire

Girman CJ, Hartmaier S, Thiboutot D, Johnson J, Barber B, DeMuro-Mercon C, Waldstreicher J et al.

To assess the health-related quality of life on individuals with facial acne

Therapeutic indications : Acne Vulgaris

default distrib

ACQ / Asthma Control Questionnaire Asthma Control Questionnaire

Juniper E et al.

To measure the adequacy of clinical asthma control

Therapeutic indications : Asthma

default distrib

ACTS / Anti-Clot Treatment Scale Anti-Clot Treatment Scale

Cano S, Lamping DL et al.

To measure patient treatment satisfaction with anticoagulation treatment

Therapeutic indications : Pulmonary Embolism, Venous Thrombosis

default distrib

ADCPQ / Alzheimer’s Disease Caregiver Preference Questionnaire Alzheimer’s Disease Caregiver Preference Questionnaire

Novartis Pharmaceuticals Corporation, Mapi et al.

To assess caregivers' satisfaction with and preference for patch or capsule treatments in Alzheimer’s Disease patients

Therapeutic indications : Alzheimer Disease

default distrib

ADCT / Atopic Dermatitis Control Tool Atopic Dermatitis Control Tool

Sanofi Group, Regeneron Pharmaceuticals Inc et al.

To measure Atopic Dermatitis (AD) disease control

Therapeutic indications : Dermatitis, Atopic

default distrib

AdolRQLQ / Adolescent Rhinoconjunctivitis Quality of Life Questionnaire Adolescent Rhinoconjunctivitis Quality of Life Questionnaire

Juniper E et al.

To measure the functional impairments that are most troublesome to patients between the ages of 12 and 17 years as a result of their rhinoconjunctivitis

Therapeutic indications : Conjunctivitis, Rhinitis

default distrib

ADPKD-IS / Autosomal Dominant Polycystic Kidney Disease Impact Scale Autosomal Dominant Polycystic Kidney Disease Impact Scale

Otsuka Pharmaceutical Development & Commercialization, Inc (USA) et al.

To measure the impact of ADPKD on patients’ lives

Therapeutic indications : Polycystic Kidney, Autosomal Dominant

default distrib

ADPKD-PDS / Autosomal Dominant Polycystic Kidney Disease Pain and Discomfort Scale Autosomal Dominant Polycystic Kidney Disease Pain and Discomfort Scale

Otsuka Pharmaceutical Development & Commercialization, Inc (USA) et al.

To understand the disease-specific burden of pain and discomfort due to ADPKD

Therapeutic indications : Polycystic Kidney, Autosomal Dominant

default distrib

ADPKD-UIS / Autosomal Dominant Polycystic Kidney Disease Urinary Impact Scale Autosomal Dominant Polycystic Kidney Disease Urinary Impact Scale

Otsuka Pharmaceutical Development & Commercialization, Inc (USA) et al.

To capture urinary impact due to ADPKD

Therapeutic indications : Polycystic Kidney, Autosomal Dominant

default distrib

ADRQL / Alzheimer's Disease-Related Quality of Life Alzheimer's Disease-Related Quality of Life

Black BS, Kasper JD, Rabins PV et al.

To evaluate treatment interventions in Alzheimer's Disease

Therapeutic indications : Alzheimer Disease

default distrib

AES-C / Apathy Evaluation Scale - Clinician version Apathy Evaluation Scale - Clinician version

Marin RS, Biedrzycki RC, Firinciogullari S et al.

To quantify and characterize apathy in adult and elderly patients

Therapeutic indications : Apathy